Invasive Non-Typhi Salmonella Disease in Africa

SC Morpeth, HO Ramadhani… - Clinical Infectious …, 2009 - academic.oup.com
Invasive non-Typhi Salmonella is endemic to sub-Saharan Africa, where it is a leading cause
of bloodstream infection. Some host risk factors have been established, but little is known …

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

…, P Moradi Choghakabodi, SC Morpeth… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

…, BJ McVerry, SK Montgomery, SC Morpeth… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

…, A McGlothlin, Z McQuilten, SC Morpeth… - Clinical Infectious …, 2022 - academic.oup.com
Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious
disease, with a 90-day mortality of 15%–30%. Despite this, <3000 people have been …

Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study

…, JL McLellan, JL Mitchell, DP Moore, SC Morpeth… - The Lancet, 2019 - thelancet.com
Background Pneumonia is the leading cause of death among children younger than 5 years.
In this study, we estimated causes of pneumonia in young African and Asian children, using …

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

…, P Meza-Meneses, WM Monteiro, SC Morpeth… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania

…, R Shah, HJ Shao, SC Morpeth… - Clinical infectious …, 2007 - academic.oup.com
Background . Access to antiretroviral therapy is rapidly expanding in sub-Saharan Africa.
Identifying the predictors of incomplete adherence, virologic failure, and antiviral drug …

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae …

LL Hammitt, DO Akech, SC Morpeth, A Karani… - The Lancet Global …, 2014 - thelancet.com
Background The effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed
countries was enhanced by indirect protection of unvaccinated individuals, mediated by …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

…, BJ McVerry, SK Montgomery, SC Morpeth… - Intensive care …, 2021 - Springer
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …

Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania

…, LY Yang, SC Chow, SC Morpeth… - Clinical infectious …, 2011 - academic.oup.com
(See the editorial commentary by Levine and Farag, on pages 349-351 .) Background . Few
studies describe patterns of human immunodeficiency virus (HIV) co-infections in African …